ATE402719T1 - Injiziebare pharmazeutische zusammensetzung enthaltend ethanol zur behandlung von bandscheibenvorfällen - Google Patents

Injiziebare pharmazeutische zusammensetzung enthaltend ethanol zur behandlung von bandscheibenvorfällen

Info

Publication number
ATE402719T1
ATE402719T1 AT03752788T AT03752788T ATE402719T1 AT E402719 T1 ATE402719 T1 AT E402719T1 AT 03752788 T AT03752788 T AT 03752788T AT 03752788 T AT03752788 T AT 03752788T AT E402719 T1 ATE402719 T1 AT E402719T1
Authority
AT
Austria
Prior art keywords
treatment
pharmaceutical composition
composition containing
injectable pharmaceutical
containing ethanol
Prior art date
Application number
AT03752788T
Other languages
English (en)
Inventor
Jacques Theron
Original Assignee
Jacques Theron
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jacques Theron filed Critical Jacques Theron
Application granted granted Critical
Publication of ATE402719T1 publication Critical patent/ATE402719T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Massaging Devices (AREA)
AT03752788T 2002-05-07 2003-05-07 Injiziebare pharmazeutische zusammensetzung enthaltend ethanol zur behandlung von bandscheibenvorfällen ATE402719T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0205819A FR2839450B1 (fr) 2002-05-07 2002-05-07 Preparation medicamenteuse notamment pour le traitement des hernies discales

Publications (1)

Publication Number Publication Date
ATE402719T1 true ATE402719T1 (de) 2008-08-15

Family

ID=29286406

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03752788T ATE402719T1 (de) 2002-05-07 2003-05-07 Injiziebare pharmazeutische zusammensetzung enthaltend ethanol zur behandlung von bandscheibenvorfällen

Country Status (14)

Country Link
US (3) US20070116647A1 (de)
EP (1) EP1503803B1 (de)
CN (1) CN100402020C (de)
AT (1) ATE402719T1 (de)
AU (1) AU2003262617A1 (de)
CA (1) CA2498976C (de)
CY (1) CY1108413T1 (de)
DE (1) DE60322530D1 (de)
DK (1) DK1503803T3 (de)
ES (1) ES2309334T3 (de)
FR (1) FR2839450B1 (de)
PT (1) PT1503803E (de)
SI (1) SI1503803T1 (de)
WO (1) WO2003097108A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2839450B1 (fr) * 2002-05-07 2006-04-07 Aboville Marc D Preparation medicamenteuse notamment pour le traitement des hernies discales
FR2891461B1 (fr) * 2005-09-30 2010-09-03 Jacques Theron Preparation medicamenteuse visqueuse injectable comprenant de l'ethanol et un compose liposoluble opaque aux rayons x.
WO2018160926A1 (en) * 2017-03-02 2018-09-07 Duke University Methods for the treatment of cancer and benign lesions by ablation
CA3075205A1 (en) 2017-09-08 2019-03-14 Mina Therapeutics Limited Stabilized hnf4a sarna compositions and methods of use
EP4219715A3 (de) 2017-09-08 2023-09-06 MiNA Therapeutics Limited Stabilisierte cebpa-sarna-zusammensetzungen und verfahren zur verwendung
EP4017539A1 (de) 2019-08-19 2022-06-29 MiNA Therapeutics Limited Oligonukleotidkonjugatzusammensetzungen und verwendungsverfahren
WO2022184176A1 (zh) * 2021-03-04 2022-09-09 苏州医本生命科技有限公司 一种含乙醇的药物组合物及其用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2162028A (en) * 1938-06-25 1939-06-13 Pittsburgh Plate Glass Co Cellulose ether coating composition
US2903396A (en) * 1957-05-08 1959-09-08 Ciba Pharm Prod Inc Therapeutic compositions and method for treating parkinsonism
EP0304403A3 (de) * 1987-08-21 1990-12-12 Ciba-Geigy Ag Kunststoffzusammensetzung mit Supraleitern
JPH02157029A (ja) 1988-12-09 1990-06-15 Dainippon Pharmaceut Co Ltd アニオン系界面活性剤含有組成物の安定化
US5830178A (en) * 1996-10-11 1998-11-03 Micro Therapeutics, Inc. Methods for embolizing vascular sites with an emboilizing composition comprising dimethylsulfoxide
US6476070B2 (en) * 1997-09-11 2002-11-05 Provasis Therapeutics Inc. Compositions useful for remodeling body spaces
US6015541A (en) * 1997-11-03 2000-01-18 Micro Therapeutics, Inc. Radioactive embolizing compositions
US6150022A (en) * 1998-12-07 2000-11-21 Flex Products, Inc. Bright metal flake based pigments
EP1987847A1 (de) * 1999-05-21 2008-11-05 Micro Therapeutics, Inc. Neuartige Embolisierungszusammensetzungen mit hoher Viskosität
AU5144600A (en) * 1999-05-21 2000-12-12 Micro Therapeutics, Inc. Methods for embolizing vascular sites with an embolizing composition
US6355058B1 (en) * 1999-12-30 2002-03-12 Advanced Cardiovascular Systems, Inc. Stent with radiopaque coating consisting of particles in a binder
US20020115904A1 (en) * 2001-02-21 2002-08-22 Brooke Ren Magnetically controllable embolic materials
FR2839450B1 (fr) * 2002-05-07 2006-04-07 Aboville Marc D Preparation medicamenteuse notamment pour le traitement des hernies discales

Also Published As

Publication number Publication date
CA2498976A1 (fr) 2003-11-27
SI1503803T1 (sl) 2008-12-31
FR2839450B1 (fr) 2006-04-07
US8153696B2 (en) 2012-04-10
US20100329991A1 (en) 2010-12-30
US20130143970A1 (en) 2013-06-06
CN100402020C (zh) 2008-07-16
FR2839450A1 (fr) 2003-11-14
CY1108413T1 (el) 2014-02-12
EP1503803A1 (de) 2005-02-09
PT1503803E (pt) 2008-10-16
ES2309334T3 (es) 2008-12-16
US20070116647A1 (en) 2007-05-24
DK1503803T3 (da) 2008-11-10
DE60322530D1 (de) 2008-09-11
WO2003097108A1 (fr) 2003-11-27
HK1081849A1 (zh) 2006-05-26
CA2498976C (fr) 2011-09-06
CN1665546A (zh) 2005-09-07
EP1503803B1 (de) 2008-07-30
AU2003262617A1 (en) 2003-12-02

Similar Documents

Publication Publication Date Title
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
CY1105120T1 (el) Η αντιμετωπιση αναπνευστικων νοσων
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
CY1107294T1 (el) Τοπικη συνθεση η οποια περιεχει τουλαχιστον μια βιταμινη d ή ενα αναλογο της βιταμινης d και τουλαχιστον ενα κορτικοστεροειδες
BR0015188A (pt) Composições farmacêuticas
EE200300212A (et) Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks
CY1107512T1 (el) Νεες υποκατεστημενες με βενζιμιδαζολιο μορφες δοσολογιας και μεθοδος για τη χρηση τους
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
CY1109013T1 (el) Νεα 4,4΄-διθειοδις-(3-αμινοβουτανιο-1-σουλφονικα) παραγωγα και συνθεσεις που τα περιεχουν
CU23043A1 (es) Composicion farmaceutica que contiene factor de crecimiento epidrmico (egf) para la prevencion de la amputacion de pie diabetico.
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
CY1108413T1 (el) Ενεσιμη φαρμακευτικη συνθεση που περιλαμβανει αιθανολη για την αγωγη των δισκοπαθειων
DE69716469D1 (de) Pharmazeutische zusammensetzung enthaltend ein osteogenese foerderndes mittel und ein polyethylen-glycol
DE60105025D1 (de) Pharmazeutische verbindungen zur behandlung von chronisch-obstruktiver bronchopneumonie
DE60027209D1 (de) Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen
TR200100895T2 (tr) Heterosiklik ikameli propanolamin türevleri, üretimi, ilaçları,kullanımı
ATE464878T1 (de) Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl
CY1107231T1 (el) Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης
TW200509863A (en) Irradiation device for medical use
WO2004073615A8 (en) Deazaflavin compounds and methods of use thereof
CL2004001421A1 (es) Composicion farmaceutica que comprende un compuesto derivado de 1,4-dipiperidin-4-il-piperazina; y su uso para la prevencion y/o tratamiento del dolor.
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
ATE439125T1 (de) Fenofibrate tablett und verfahren zur herstellung
ATE487492T1 (de) Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1503803

Country of ref document: EP